Literature DB >> 30905713

Respiration Enhances TDP-43 Toxicity, but TDP-43 Retains Some Toxicity in the Absence of Respiration.

Sei-Kyoung Park1, Sangeun Park1, Susan W Liebman2.   

Abstract

The trans-activating response DNA-binding protein 43 (TDP-43) is a transcriptional repressor and splicing factor. TDP-43 is normally mostly in the nucleus, although it shuttles to the cytoplasm. Mutations in TDP-43 are one cause of familial amyotrophic lateral sclerosis. In neurons of these patients, TDP-43 forms cytoplasmic aggregates. In addition, wild-type TDP-43 is also frequently found in neuronal cytoplasmic aggregates in patients with neurodegenerative diseases not caused by TDP-43 mutations. TDP-43 expressed in yeast causes toxicity and forms cytoplasmic aggregates. This disease model has been validated because genetic modifiers of TDP-43 toxicity in yeast have led to the discovery that their conserved genes in humans are amyotrophic lateral sclerosis genetic risk factors. While how TDP-43 is associated with toxicity is unknown, several studies find that TDP-43 alters mitochondrial function. We now report that TDP-43 is much more toxic when yeast are respiring than when grown on a carbon source where respiration is inhibited. However, respiration is not the unique target of TDP-43 toxicity because we found that TDP-43 retains some toxicity even in the absence of respiration. We found that H2O2 increases the toxicity of TDP-43, suggesting that the reactive oxygen species associated with respiration could likewise enhance the toxicity of TDP-43. In this case, the TDP-43 toxicity targets in the presence or absence of respiration could be identical, with the reactive oxygen species produced by respiration activating TDP-43 to become more toxic or making TDP-43 targets more vulnerable.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  TDP-43; amyotrophic lateral sclerosis; mitochondria; respiration; yeast

Mesh:

Substances:

Year:  2019        PMID: 30905713      PMCID: PMC6502655          DOI: 10.1016/j.jmb.2019.03.014

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  37 in total

1.  TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy.

Authors:  Ann C McKee; Brandon E Gavett; Robert A Stern; Christopher J Nowinski; Robert C Cantu; Neil W Kowall; Daniel P Perl; E Tessa Hedley-Whyte; Bruce Price; Chris Sullivan; Peter Morin; Hyo-Soon Lee; Caroline A Kubilus; Daniel H Daneshvar; Megan Wulff; Andrew E Budson
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

2.  Biochemical and genetic methods for characterization of [PIN+] prions in yeast.

Authors:  Susan W Liebman; Sviatoslav N Bagriantsev; Irina L Derkatch
Journal:  Methods       Date:  2006-05       Impact factor: 3.608

3.  TDP-43 and FUS: a nuclear affair.

Authors:  Dorothee Dormann; Christian Haass
Journal:  Trends Neurosci       Date:  2011-06-22       Impact factor: 13.837

4.  Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice.

Authors:  Xiu Shan; Po-Min Chiang; Donald L Price; Philip C Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-24       Impact factor: 11.205

5.  Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice.

Authors:  Ya-Fei Xu; Tania F Gendron; Yong-Jie Zhang; Wen-Lang Lin; Simon D'Alton; Hong Sheng; Monica Castanedes Casey; Jimei Tong; Joshua Knight; Xin Yu; Rosa Rademakers; Kevin Boylan; Mike Hutton; Eileen McGowan; Dennis W Dickson; Jada Lewis; Leonard Petrucelli
Journal:  J Neurosci       Date:  2010-08-11       Impact factor: 6.167

6.  Variant-specific [PSI+] infection is transmitted by Sup35 polymers within [PSI+] aggregates with heterogeneous protein composition.

Authors:  Sviatoslav N Bagriantsev; Elena O Gracheva; Janet E Richmond; Susan W Liebman
Journal:  Mol Biol Cell       Date:  2008-03-19       Impact factor: 4.138

7.  A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity.

Authors:  Brian S Johnson; J Michael McCaffery; Susan Lindquist; Aaron D Gitler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

8.  Widespread protein aggregation as an inherent part of aging in C. elegans.

Authors:  Della C David; Noah Ollikainen; Jonathan C Trinidad; Michael P Cary; Alma L Burlingame; Cynthia Kenyon
Journal:  PLoS Biol       Date:  2010-08-10       Impact factor: 8.029

9.  Neurotoxic 43-kDa TAR DNA-binding protein (TDP-43) triggers mitochondrion-dependent programmed cell death in yeast.

Authors:  Ralf J Braun; Cornelia Sommer; Didac Carmona-Gutierrez; Chamel M Khoury; Julia Ring; Sabrina Büttner; Frank Madeo
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.486

10.  Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS.

Authors:  Andrew C Elden; Hyung-Jun Kim; Michael P Hart; Alice S Chen-Plotkin; Brian S Johnson; Xiaodong Fang; Maria Armakola; Felix Geser; Robert Greene; Min Min Lu; Arun Padmanabhan; Dana Clay-Falcone; Leo McCluskey; Lauren Elman; Denise Juhr; Peter J Gruber; Udo Rüb; Georg Auburger; John Q Trojanowski; Virginia M-Y Lee; Vivianna M Van Deerlin; Nancy M Bonini; Aaron D Gitler
Journal:  Nature       Date:  2010-08-26       Impact factor: 49.962

View more
  7 in total

Review 1.  TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.

Authors:  Ju Gao; Luwen Wang; Tingxiang Yan; George Perry; Xinglong Wang
Journal:  Mol Cell Neurosci       Date:  2019-08-21       Impact factor: 4.314

Review 2.  Application of yeast to studying amyloid and prion diseases.

Authors:  Yury O Chernoff; Anastasia V Grizel; Aleksandr A Rubel; Andrew A Zelinsky; Pavithra Chandramowlishwaran; Tatiana A Chernova
Journal:  Adv Genet       Date:  2020-05-04       Impact factor: 1.944

3.  Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy.

Authors:  Koji Matsukawa; Michail S Kukharsky; Sei-Kyoung Park; Sangeun Park; Naruaki Watanabe; Takeshi Iwatsubo; Tadafumi Hashimoto; Susan W Liebman; Tatyana A Shelkovnikova
Journal:  RNA Biol       Date:  2021-01-11       Impact factor: 4.766

Review 4.  Oxidative Stress in Amyotrophic Lateral Sclerosis: Synergy of Genetic and Environmental Factors.

Authors:  Anca Motataianu; Georgiana Serban; Laura Barcutean; Rodica Balasa
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

Review 5.  Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship.

Authors:  Niccolò Candelise; Illari Salvatori; Silvia Scaricamazza; Valentina Nesci; Henri Zenuni; Alberto Ferri; Cristiana Valle
Journal:  Metabolites       Date:  2022-03-09

Review 6.  Maintaining the balance of TDP-43, mitochondria, and autophagy: a promising therapeutic strategy for neurodegenerative diseases.

Authors:  Chunhui Huang; Sen Yan; Zaijun Zhang
Journal:  Transl Neurodegener       Date:  2020-10-30       Impact factor: 8.014

7.  Sulfotransferase 4A1 activity facilitates sulfate-dependent cellular protection to oxidative stress.

Authors:  Evan J Brettrager; Arthur W Meehan; Charles N Falany; Robert C A M van Waardenburg
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.